Collegium Pharmaceutical (COLL) Retained Earnings (2016 - 2026)
Collegium Pharmaceutical has reported Retained Earnings over the past 11 years, most recently at $319000.0 for Q4 2025.
- For Q4 2025, Retained Earnings rose 480.0% year-over-year to $319000.0; the TTM value through Dec 2025 reached $319000.0, up 480.0%, while the annual FY2025 figure was $319000.0, 480.0% up from the prior year.
- Retained Earnings for Q4 2025 was $319000.0 at Collegium Pharmaceutical, up from $292000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $337000.0 in Q2 2025 and troughed at -$312.2 million in Q1 2021.
- A 5-year average of -$139.9 million and a median of -$181.2 million in 2024 define the central range for Retained Earnings.
- Biggest five-year swings in Retained Earnings: tumbled 489031.58% in 2024 and later skyrocketed 480.0% in 2025.
- Year by year, Retained Earnings stood at -$256.3 million in 2021, then dropped by 9.75% to -$281.3 million in 2022, then skyrocketed by 100.0% to $14000.0 in 2023, then skyrocketed by 292.86% to $55000.0 in 2024, then skyrocketed by 480.0% to $319000.0 in 2025.
- Business Quant data shows Retained Earnings for COLL at $319000.0 in Q4 2025, $292000.0 in Q3 2025, and $337000.0 in Q2 2025.